Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lifebit is an active UK-based precision medicine software company founded in London in April 2017. It specializes in federated genomic and health data platforms that allow researchers to securely access and analyze distributed clinical/multiomic datasets without moving sensitive information outside institutional boundaries. The company's flagship product suite includes the "Lifebit CloudOS" platform as well as custom federated solutions supporting global biopharma leaders such as Boehringer Ingelheim, national genomics initiatives like Genomics England, healthcare systems such as Synapxe Singapore Health Services, and numerous academic partners. While it does not develop drugs or diagnostics itself—and thus has no therapeutic pipeline—it plays a critical role enabling biomedical discovery by integrating genetic with clinical information at scale across more than five continents. Its technologies are widely adopted for translational research acceleration (>100 million patient records supported), especially where privacy-preserving analytics on siloed or sensitive health/genetic data are required.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lifebit.